Cencora, Inc. logo

Cencora, Inc. (COR)

Market Closed
12 Jun, 20:00
NYSE NYSE
$
281. 80
+0.32
+0.1137%
$
54.39B Market Cap
23.39 P/E Ratio
2.4% Div Yield
840,923 Volume
11.93 Eps
$ 281.48
Previous Close
Add Transaction
Day Range
279.62 283.84
Year Range
244.82 377.54
Want to track COR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

COR closed today higher at $281.8, an increase of 0.1137% from yesterday's close, completing a monthly increase of 5.0904% or $13.65. Over the past 12 months, COR stock lost -16.4245%.
COR pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 2 months on Sep 01, 2026 for a total of $0.6.
The last earnings report, released on May 05, 2026, missed the consensus estimates by -4.89%. On average, the company has fell short of earnings expectations by -1.6133%, based on the last three reports.
Cencora, Inc. has completed 4 stock splits, with the recent split occurring on Jun 16, 2009.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

COR Chart

People also search for

BUD
Anheuser-Busch InBev S.A. ADR
$ 82.88
+0.7415%
BTI
British American Tobacco p.l.c. ADR
$ 62.34
+1.5393%
UL
Unilever PLC Sponsored American Depositary Receipt
$ 58.94
+1.0631%
MO
Altria Group, Inc.
$ 71.93
+0.7282%
MCK
McKesson Corporation
$ 784.35
-0.3608%
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed

Cencora's Specialty Supply Chain: Where COR's Growth Is Headed

COR bets on MSOs, specialty logistics and AI tools to deepen ties beyond distribution???even as GLP-1 mix and pricing swings cloud results.

Zacks | 1 week ago
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?

Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 week ago
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know

Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know

The mean of analysts' price targets for Cencora (COR) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks | 1 week ago

Cencora, Inc. (COR) FAQ

What is the stock price today?

The current price is $281.80.

On which exchange is it traded?

Cencora, Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is COR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, the market cap is 54.39B.

Has Cencora, Inc. ever had a stock split?

Cencora, Inc. had 4 splits and the recent split was on Jun 16, 2009.

Cencora, Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Robert Mauch CEO
NYSE Exchange
03090BBJ8 CUSIP
US Country
47,000 Employees
1 Jun 2026 Last Dividend
16 Jun 2009 Last Split
4 Apr 1995 IPO Date

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, is a global leader in healthcare solutions, with a focus on improving patient outcomes through the efficient distribution and commercialization of pharmaceuticals and healthcare-related products. Established in 2001 and headquartered in Conshohocken, Pennsylvania, Cencora has expanded its reach by providing a wide range of services to various healthcare providers, including acute care hospitals, retail pharmacies, mail order pharmacies, and specialists across numerous disease states. The company's commitment to offering comprehensive supply chain management services, specialized software, and consulting services underscores its integral role in the healthcare sector. Through its U.S. Healthcare Solutions and International Healthcare Solutions segments, Cencora, Inc. addresses the nuanced needs of its global client base, delivering tailored services that encompass distribution, commercialization, logistics, and much more.

Products and Services

  • Pharmaceutical Distribution - Cencora's core service involves the distribution of pharmaceuticals, including over-the-counter healthcare products, home healthcare supplies and equipment, to a wide range of healthcare providers like hospitals, pharmacies, and clinics. This ensures that essential medicines and healthcare supplies reach those in need efficiently.
  • Pharmacy Management and Consulting Services - Offering pharmacy management, staffing, and consulting services, Cencora supports retail and institutional healthcare providers in optimizing their operations for better service delivery and improved patient care.
  • Supply Management Software - The company provides advanced supply management software solutions that help healthcare providers streamline their operational processes, ensuring that they can focus on patient care without worrying about inventory and supply chain issues.
  • Packaging Solutions - Tailored packaging solutions are offered to healthcare providers, facilitating the safe and reliable distribution of pharmaceuticals and healthcare products.
  • Clinical Trial Support - Supporting biotechnology and pharmaceutical manufacturers with clinical trial support, product post-approval, and commercialization support services, Cencora plays a crucial role in bringing new treatments to market.
  • Data Analytics and Research Services - By providing comprehensive data analytics, outcomes research services, and additional support services, Cencora aids manufacturers and healthcare providers in understanding market trends, patient outcomes, and more, enhancing healthcare delivery.
  • Animal Health Products - The company also caters to the companion animal and production animal markets, offering pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients, supporting veterinary care providers in maintaining animal health.
  • Specialty Products Distribution - Includes the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and specialty products to healthcare providers specializing in various disease states, including oncology.
  • International Healthcare Solutions - Through its international segment, Cencora offers pharmaceutical wholesale, related services, and global commercialization services, emphasizing its role in the international healthcare supply chain. This also includes specialty transportation and logistics services for the biopharmaceutical industry, reflecting the company’s adaptability to the unique needs of global markets.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000